Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients (Q84511640)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1 reference

Christoph Ausch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Veronika Buxhofer-Ausch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ulrike Olszewski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Rudolf Schiessel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Emil Ogris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Wolfgang Hinterberger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Gerhard Hamilton

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

2 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastrointestinal Surgery

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

2020-2026

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables

6 February 2020

cites work

1 reference

12 December 2020

Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.

1 reference

12 December 2020

Assessment of apoptosis by M30 immunoreactivity and the correlation with morphological criteria in normal colorectal mucosa, adenomas and carcinomas

1 reference

12 December 2020

Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.

1 reference

12 December 2020

Cytokeratin markers come of age.

1 reference

12 December 2020

Measurement of an apoptotic product in the sera of breast cancer patients

1 reference

12 December 2020

Bone marrow aspiration for disseminated tumor cell detection: a must-have test or is the jury still out?

1 reference

12 December 2020

Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: clinicopathological correlation and prognostic value in colorectal cancer patients

1 reference

12 December 2020

Cancer-associated cleavage of cytokeratin 8/18 heterotypic complexes exposes a neoepitope in human adenocarcinomas

1 reference

12 December 2020

The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival

1 reference

12 December 2020

Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients

1 reference

12 December 2020

Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.

1 reference

12 December 2020

Spontaneous changes in tumour cell dissemination to bone marrow in colorectal cancer

1 reference

12 December 2020

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis

1 reference

12 December 2020

Repair of full-thickness bowel injury

1 reference

12 December 2020

Detection, clinical relevance and specific biological properties of disseminating tumour cells

1 reference

12 December 2020

Detection of epithelial cell death in the body by cytokeratin 18 measurement

1 reference

12 December 2020

Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer

1 reference

12 December 2020

Clinical utility of cytokeratins as tumor markers

1 reference

12 December 2020

Surgical therapy for colorectal adenocarcinoma

1 reference

12 December 2020

Circulating cell death products predict clinical outcome of colorectal cancer patients

1 reference

12 December 2020

Optimisation of circulating biomarkers of cell death for routine clinical use.

1 reference

12 December 2020

Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update

1 reference

12 December 2020

Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer

1 reference

12 December 2020

10.1007/S11605-009-0992-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727975%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference